Antimicrobial Pharmacodynamics in Theory and Clinical Practice (2nd Ed.)
Introduction. Pharmacodynamics of Antimicrobials: General Concepts and Applications Impact of Pharmacodynamics on Breakpoint Selection for Susceptibility Testing. Non-Clinical Models of Infection. In Vitro Antibiotic Pharmacokinetic Models. Animal Models of Infection for the Study of Antibiotic Pharmacodynamics. The Predictive Value of Laboratory Tests for Efficacy of Antibiotic Combination Therapy. Antibacterial Agents. Beta-Lactam Antibiotics. Aminoglycoside Antibiotics. Quinolones. Glycopeptides. Macrolide, Azalide and Ketolides. Metronidazole, and Clindamycin. Streptogramins, Oxazolididones. Tetracyclines. Antiviral Agents. Nucleoside Reverse Transcriptase Inhibitors. Protease Inhibitors. Hepatitis B and C. Antifungal Agents. Amphotericin. Azoles. Gulcan Synthase Inhibitors. Antimalarial Agents. Anti-Malarials. Pharmacodynamics in Drug Development. Human Pharmacodynamics of Anti-Infectives: Determination from Clinical Trial Data. Pharmacodynamics in Global Bridging Studies. Toxicodynamics. Pharmacodynamics and Resistance. Antibacterial Resistance. Application of PK-PD to Clinical and Formulary Decisions. Basic Pharmacoeconomics. Utilizing Pharmacodynamics and Pharmacoeconomics in Clinical and Formulary Decision Making.
Date de parution : 09-2019
15.2x22.9 cm
Date de parution : 06-2007
Ouvrage de 550 p.
15.2x22.9 cm
Mots-clés :
Mic; Plasma Concentrations; Daily AUC; PAE; Mic Distribution; Log10 CFU; Time Kill Curve; Pk PD Relationship; Susceptibility Breakpoints; Pe Rc; Vancomycin Resistant Enterococcus; MPC; Time Dependent Killing; Dosing Interval; Murine Thigh Infection Model; Mic Value; Mic Ratio; Dose Fractionation Studies; Target Attainment Rate; Gram Negative Bacilli; Post-antibiotic Effect; PD Index; Pharmacodynamic Parameter; Concentration Time Curve; Li Ne